Edward Miller, MD, PHD

NPI: 1366617458
Total Payments
$100,638
2024 Payments
$20,000
Companies
7
Transactions
33
Medicare Patients
1,942
Medicare Billing
$120,618

Payment Breakdown by Category

Other$51,905 (51.6%)
Consulting$45,095 (44.8%)
Travel$3,210 (3.2%)
Food & Beverage$428.45 (0.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $45,095 16 44.8%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $24,404 5 24.2%
Grant $20,000 1 19.9%
Honoraria $7,501 4 7.5%
Travel and Lodging $3,210 3 3.2%
Food and Beverage $428.45 4 0.4%

Top Paying Companies

Company Total Records Latest Year
GE HEALTHCARE $48,768 18 $0 (2018)
PFIZER INC. $42,546 7 $0 (2024)
BRACCO DIAGNOSTICS INC. $5,681 4 $0 (2019)
CSL Behring $3,395 1 $0 (2023)
Akcea Therapeutics, Inc. $121.41 1 $0 (2019)
Alnylam Pharmaceuticals Inc. $68.18 1 $0 (2023)
Mallinckrodt LLC $58.63 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $20,000 1 PFIZER INC. ($20,000)
2023 $10,405 4 PFIZER INTERNATIONAL LLC ($6,942)
2020 $2,000 1 PFIZER INC. ($2,000)
2019 $3,269 2 BRACCO DIAGNOSTICS INC. ($3,148)
2018 $57,737 16 GE HEALTHCARE ($41,600)
2017 $7,227 9 GE HEALTHCARE ($7,168)

All Payment Transactions

33 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
10/28/2024 PFIZER INC. Grant Cash or cash equivalent $20,000.00 General
06/23/2023 Alnylam Pharmaceuticals Inc. AMVUTTRA (Drug) Food and Beverage In-kind items and services $68.18 General
Category: Genetic Disease
06/12/2023 PFIZER INTERNATIONAL LLC VYNDAQEL (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,004.00 General
Category: CARDIOVASCULAR
05/06/2023 PFIZER INC. VYNDAMAX (Drug) Travel and Lodging In-kind items and services $1,938.24 General
Category: CARDIOVASCULAR
02/22/2023 CSL Behring Consulting Fee Cash or cash equivalent $3,395.00 General
08/27/2020 PFIZER INC. VYNDAQEL (Drug) Honoraria Cash or cash equivalent $2,000.00 General
Category: CARDIOVASCULAR
09/13/2019 Akcea Therapeutics, Inc. TEGSEDI (Drug) Food and Beverage In-kind items and services $121.41 General
Category: NEUROLOGY
04/02/2019 BRACCO DIAGNOSTICS INC. CardioGen (Drug) Honoraria Cash or cash equivalent $3,147.73 General
Category: CONTRAST MEDIA
12/24/2018 PFIZER INC. Consulting Fee Cash or cash equivalent $8,800.00 General
11/13/2018 GE HEALTHCARE Consulting Fee Cash or cash equivalent $4,700.00 General
11/13/2018 PFIZER INC. Travel and Lodging Cash or cash equivalent $803.32 General
10/22/2018 PFIZER INC. Consulting Fee Cash or cash equivalent $4,000.00 General
10/02/2018 GE HEALTHCARE Consulting Fee Cash or cash equivalent $3,000.00 General
09/18/2018 GE HEALTHCARE Consulting Fee Cash or cash equivalent $11,900.00 General
07/17/2018 GE HEALTHCARE Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,400.00 General
07/05/2018 GE HEALTHCARE Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $7,500.00 General
07/04/2018 GE HEALTHCARE Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $7,500.00 General
06/12/2018 GE HEALTHCARE Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,000.00 General
05/01/2018 BRACCO DIAGNOSTICS INC. CardioGen (Drug) Honoraria Cash or cash equivalent $2,000.00 General
Category: CONTRAST MEDIA
05/01/2018 BRACCO DIAGNOSTICS INC. CardioGen (Drug) Honoraria Cash or cash equivalent $352.96 General
Category: CONTRAST MEDIA
03/20/2018 GE HEALTHCARE Consulting Fee Cash or cash equivalent $1,700.00 General
03/09/2018 BRACCO DIAGNOSTICS INC. NUCLEAR (GROUP) (Drug) Food and Beverage Cash or cash equivalent $180.23 General
Category: CONTRAST MEDIA
01/30/2018 GE HEALTHCARE Consulting Fee Cash or cash equivalent $200.00 General
01/09/2018 GE HEALTHCARE Consulting Fee Cash or cash equivalent $700.00 General
11/28/2017 GE HEALTHCARE Consulting Fee Cash or cash equivalent $1,600.00 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 423 430 $139,020 $23,204
2022 9 453 462 $154,570 $28,310
2021 10 473 496 $170,125 $32,016
2020 12 593 613 $202,805 $37,089
Total Patients
1,942
Total Services
2,001
Medicare Billing
$120,618
Procedure Codes
44

All Medicare Procedures & Services

44 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
78452 Nuclear medicine studies of heart muscle at rest and with stress and spect Facility 2023 72 72 $27,360 $4,408 16.1%
78431 Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan Facility 2023 55 55 $20,625 $3,930 19.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 37 43 $16,125 $3,117 19.3%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 18 18 $12,330 $2,675 21.7%
78452 Nuclear medicine studies of heart muscle at rest and with stress and spect Office 2023 32 32 $12,160 $1,916 15.8%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 12 12 $8,520 $1,838 21.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 17 18 $8,910 $1,816 20.4%
78434 Nuclear medicine study of heart muscle blood flow by pet Facility 2023 55 55 $6,875 $1,324 19.3%
93018 Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician Facility 2023 102 102 $18,870 $1,102 5.8%
78451 Nuclear medicine study of heart muscle at rest and with stress and spect Facility 2023 23 23 $7,245 $1,078 14.9%
78431 Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan Facility 2022 75 75 $28,125 $5,493 19.5%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 31 31 $21,235 $5,174 24.4%
78452 Nuclear medicine studies of heart muscle at rest and with stress and spect Facility 2022 59 59 $22,420 $3,384 15.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 30 37 $13,875 $2,920 21.0%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 22 24 $11,880 $2,844 23.9%
78452 Nuclear medicine studies of heart muscle at rest and with stress and spect Office 2022 42 42 $15,960 $2,615 16.4%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 13 13 $9,230 $2,020 21.9%
78434 Nuclear medicine study of heart muscle blood flow by pet Facility 2022 75 75 $9,375 $1,819 19.4%
78451 Nuclear medicine study of heart muscle at rest and with stress and spect Facility 2022 22 22 $6,930 $1,112 16.0%
93018 Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician Facility 2022 84 84 $15,540 $928.86 6.0%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 39 39 $26,715 $6,695 25.1%
78452 Nuclear medicine study of vessels of heart using drugs or exercise multiple studies Facility 2021 78 78 $29,640 $4,956 16.7%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 41 53 $19,875 $4,417 22.2%
78431 Multiple nuclear medicine studies of blood flow in heart muscle at rest and with stress, with concurrently acquired ct transmission scan Facility 2021 48 48 $18,000 $3,132 17.4%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 21 23 $11,385 $2,930 25.7%

About Edward Miller, MD, PHD

Edward Miller, MD, PHD is a Cardiovascular Disease healthcare provider based in New Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/29/2008. The National Provider Identifier (NPI) number assigned to this provider is 1366617458.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Edward Miller, MD, PHD has received a total of $100,638 in payments from pharmaceutical and medical device companies, with $20,000 received in 2024. These payments were reported across 33 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($45,095).

As a Medicare-enrolled provider, Miller has provided services to 1,942 Medicare beneficiaries, totaling 2,001 services with total Medicare billing of $120,618. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.

Practice Information

  • Specialty Cardiovascular Disease
  • Other Specialties Cardiovascular Disease, Internal Medicine
  • Location New Haven, CT
  • Active Since 04/29/2008
  • Last Updated 07/14/2015
  • Taxonomy Code 207RC0000X
  • Entity Type Individual
  • NPI Number 1366617458

Products in Payments

  • VYNDAQEL (Drug) $7,004
  • CardioGen (Drug) $5,501
  • VYNDAMAX (Drug) $1,938
  • NUCLEAR (GROUP) (Drug) $180.23
  • TEGSEDI (Drug) $121.41
  • AMVUTTRA (Drug) $68.18
  • ACTHAR (Biological) $58.63

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Cardiovascular Disease Doctors in New Haven